Clinical lasting response of crizotinib in ALK positive lung squamous cell carcinoma with brain metastasis. European Journal of Oncology and Environmental Health, [S. l.], v. 22, n. 2, p. 95–97, 2017. Disponível em: https://mattioli1885journals.com/index.php/EJOEH/article/view/4800.. Acesso em: 18 jul. 2024.